StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)

Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –

Integra LifeSciences operating margin

Operating margin is operating income as a percentage of revenue.

Integra LifeSciences's operating margin for the twelve months ending Sep 30, 2026 was 4.4%. For fiscal 2025 it was -30.2%, against 1.8% the year before. The highest annual figure on record is 15.3% in fiscal 2022.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-30.2%−31.9
FY2024Dec 31, 20241.8%−5.5
FY2023Dec 31, 20237.2%−8.1
FY2022Dec 31, 202215.3%+2.6
FY2021Dec 31, 202112.8%+1.8
FY2020Dec 31, 202011.0%+4.9
FY2019Dec 31, 20196.2%−1.4
FY2018Dec 31, 20187.5%+3.8
FY2017Dec 31, 20173.8%−7.9
FY2016Dec 31, 201611.6%+2.6
FY2015Dec 31, 20159.0%+0.5
FY2014Dec 31, 20148.5%+3.4
FY2013Dec 31, 20135.1%−3.8
FY2012Dec 31, 20128.9%+1.8
FY2011Dec 31, 20117.0%−6.4
FY2010Dec 31, 201013.5%−0.9
FY2009Dec 31, 200914.3%+7.1
FY2008Dec 31, 20087.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 20264.6%+1.7
Q2 FY2026Jun 30, 20264.6%+128.0
Q1 FY2026Mar 31, 20262.9%+7.0
Q4 FY2025Dec 31, 20255.3%−2.8
Q3 FY2025Sep 30, 20252.9%+5.1
Q2 FY2025Jun 30, 2025-123.4%−122.6
Q1 FY2025Mar 31, 2025-4.0%−5.1
Q4 FY2024Dec 31, 20248.0%−1.0
Q3 FY2024Sep 30, 2024-2.1%−9.1
Q2 FY2024Jun 30, 2024-0.7%−4.0
Q1 FY2024Mar 31, 20241.1%−8.5
Q4 FY2023Dec 31, 20239.1%−8.0
Q3 FY2023Sep 30, 20237.0%−9.9
Q2 FY2023Jun 30, 20233.3%−11.8
Q1 FY2023Mar 31, 20239.6%−2.7
Q4 FY2022Dec 31, 202217.0%+2.7
Q3 FY2022Sep 30, 202216.9%+2.3
Q2 FY2022Jun 30, 202215.0%+1.8
Q1 FY2022Mar 31, 202212.3%+3.7
Q4 FY2021Dec 31, 202114.4%+0.8
Q3 FY2021Sep 30, 202114.6%−1.0
Q2 FY2021Jun 30, 202113.3%+7.9
Q1 FY2021Mar 31, 20218.5%+0.9
Q4 FY2020Dec 31, 202013.5%+4.4
Q3 FY2020Sep 30, 202015.5%+21.0
Q2 FY2020Jun 30, 20205.4%−6.5
Q1 FY2020Mar 31, 20207.6%−1.3
Q4 FY2019Dec 31, 20199.1%+0.2
Q3 FY2019Sep 30, 2019-5.4%−11.9
Q2 FY2019Jun 30, 201912.0%+4.4
Q1 FY2019Mar 31, 20199.0%+1.8
Q4 FY2018Dec 31, 20188.9%+6.9
Q3 FY2018Sep 30, 20186.5%+2.7
Q2 FY2018Jun 30, 20187.5%+1.5
Q1 FY2018Mar 31, 20187.2%+3.3
Q4 FY2017Dec 31, 20172.0%−14.0
Q3 FY2017Sep 30, 20173.8%–
Q2 FY2017Jun 30, 20176.0%–
Q1 FY2017Mar 31, 20173.9%–
Q4 FY2016Dec 31, 201615.9%–

More Integra LifeSciences figures

See a number that looks wrong?